Application Deadline: March 3, 2025
LOCATION: USA
Lung cancer continues to be the number one cause of cancer deaths worldwide, accounting for an estimated 130,180 deaths annually in the United States alone. Despite being the most common cancer killer of both men and women, lung cancer research remains critically underfunded. To help close this gap and improve outcomes, the goal of the LCRF Leading Edge Research Grant Program is to fund innovative projects across the full spectrum of basic, translational, clinical, epidemiological, health services, early detection, disparities, and social determinants of health research.
ELIGIBILITY:
Investigators must be affiliated with a non-profit academic or research institution and must be post-doctoral researchers, clinical fellows, or early-career and mid-career investigators with less than ten years’ experience since their initial faculty appointment.
Applicants from US-based and international institutions are eligible to apply and may hold any residency/citizenship status. Any questions regarding eligibility should be directed to the LCRF Grants Office before the submission of an application.
Applicants are prohibited from applying if they have received funding from the LCRF within the last 4 years.
Applicants are prohibited from applying in more than one of LCRF’s funding tracks in the same cycle.
Senior investigators with more than ten years’ experience since faculty appointment are generally not eligible for funding and are encouraged to mentor a junior team member through the application process. However, exceptions will be made for investigators with more than ten years’ experience in other disease areas or topics.
Ineligible investigators with these or other special circumstances may request review by contacting the LCRF grants office (see Inquiries section below) before submitting an application and at least a week before submission deadline.
Ineligible applications and new requests under special circumstances will not be considered after submission deadline.
BENEFIT:
This award provides a maximum of $150,000 in funding over a period of two years.